In cancer, precision medicine?involves testing DNA from patients' tumors to identify the mutations or other genetic changes that drive their cancer.?
We aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the impact of Coronavirus COVID-19 on the Precision Cancer Therapies industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.
Market Segment by Product Type
Hormone Therapy
Immunotherapies
Targeted Therapy
Monoclonal Antibody Therapy
Gene Therapy
Market Segment by Product Application
Hospitals
Diagnostic Centers
Oncology Clinics
Research Institutes
Finally, the report provides detailed profile and data information analysis of leading company.
Abbott Laboratories
Bayer HealthCare
GlaxoSmithKline
OncoGenex Pharmaceuticals
Hospira
Boehringer Ingelheim
AstraZeneca
Aveo Pharmaceuticals
Insights and Tools:
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
Analyses of global market trends, with historical data, estimates for 2022 and projections of compound annual growth rates (CAGRs) through 2027
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global market discussed.
Research Objectives
1.To study and analyze the global Precision Cancer Therapies consumption (value) by key regions/countries, product type and application, history data from 2017 to 2021, and forecast to 2027.
2.To understand the structure of Precision Cancer Therapies market by identifying its various subsegments.
3.Focuses on the key global Precision Cancer Therapies manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Precision Cancer Therapies with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Precision Cancer Therapies submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
Global Precision Cancer Therapies Market Research Report 2022, Forecast to 2027
1 Market Study Overview
1.1 Study Objectives
1.2 Precision Cancer Therapies Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 Precision Cancer Therapies Segment by Type
2.1.1 Hormone Therapy
2.1.2 Immunotherapies
2.1.3 Targeted Therapy
2.1.4 Monoclonal Antibody Therapy
2.1.5 Gene Therapy
2.2 Market Analysis by Application
2.2.1 Hospitals
2.2.2 Diagnostic Centers
2.2.3 Oncology Clinics
2.2.4 Research Institutes
2.3 Global Precision Cancer Therapies Market Comparison by Regions (2017-2027)
2.3.1 Global Precision Cancer Therapies Market Size (2017-2027)
2.3.2 North America Precision Cancer Therapies Status and Prospect (2017-2027)
2.3.3 Europe Precision Cancer Therapies Status and Prospect (2017-2027)
2.3.4 China Precision Cancer Therapies Status and Prospect (2017-2027)
2.3.5 Japan Precision Cancer Therapies Status and Prospect (2017-2027)
2.3.6 Southeast Asia Precision Cancer Therapies Status and Prospect (2017-2027)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): Precision Cancer Therapies Industry Impact
2.5.1 Precision Cancer Therapies Business Impact Assessment - Covid-19
2.5.2 Market Trends and Precision Cancer Therapies Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Manufacturer
3.1 Global Precision Cancer Therapies Sales and Market Share by Manufacturer (2017-2022)
3.2 Global Precision Cancer Therapies Revenue and Market Share by Manufacturer (2017-2022)
3.3 Global Precision Cancer Therapies Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Precision Cancer Therapies Manufacturer Market Share
3.5 Top 10 Precision Cancer Therapies Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Precision Cancer Therapies Market
3.7 Key Manufacturers Precision Cancer Therapies Key Manufacturers
3.8 Mergers & Acquisitions Planning
4 Analysis of Precision Cancer Therapies Industry Key Manufacturers
4.1 Abbott Laboratories
4.1.1 Compan Detail
4.1.2 Abbott Laboratories Precision Cancer Therapies Product Introduction, Application and Specification
4.1.3 Abbott Laboratories 130 Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.1.4 Main Business Overview
4.1.5 Abbott Laboratories News
4.2 Bayer HealthCare
4.2.1 Compan Detail
4.2.2 Bayer HealthCare Precision Cancer Therapies Product Introduction, Application and Specification
4.2.3 Bayer HealthCare Precision Cancer Therapies Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.2.4 Main Business Overview
4.2.5 Abbott Laboratories News
4.3 GlaxoSmithKline
4.3.1 Compan Detail
4.3.2 GlaxoSmithKline Precision Cancer Therapies Product Introduction, Application and Specification
4.3.3 GlaxoSmithKline Precision Cancer Therapies Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.3.4 Main Business Overview
4.3.5 GlaxoSmithKline News
4.4 OncoGenex Pharmaceuticals
4.4.1 Compan Detail
4.4.2 OncoGenex Pharmaceuticals Precision Cancer Therapies Product Introduction, Application and Specification
4.4.3 OncoGenex Pharmaceuticals Precision Cancer Therapies Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.4.4 Main Business Overview
4.4.5 OncoGenex Pharmaceuticals News
4.5 Hospira
4.5.1 Compan Detail
4.5.2 OncoGenex Pharmaceuticals Precision Cancer Therapies Product Introduction, Application and Specification
4.5.3 Hospira Precision Cancer Therapies Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.5.4 Main Business Overview
4.5.5 Hospira News
4.6 Boehringer Ingelheim
4.6.1 Compan Detail
4.6.2 Boehringer Ingelheim Precision Cancer Therapies Product Introduction, Application and Specification
4.6.3 Boehringer Ingelheim Precision Cancer Therapies Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.6.4 Main Business Overview
4.6.5 Boehringer Ingelheim News
4.7 AstraZeneca
4.7.1 Compan Detail
4.7.2 AstraZeneca Precision Cancer Therapies Product Introduction, Application and Specification
4.7.3 AstraZeneca Precision Cancer Therapies Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.7.4 Main Business Overview
4.7.4 Main Business Overview
4.8 Aveo Pharmaceuticals
4.8.1 Compan Detail
4.8.2 Aveo Pharmaceuticals Precision Cancer Therapies Product Introduction, Application and Specification
4.8.3 Aveo Pharmaceuticals Precision Cancer Therapies Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.8.4 Main Business Overview
4.8.5 Aveo Pharmaceuticals News
5 Global Precision Cancer Therapies Market Segment by Big Type
5.1 Global Precision Cancer Therapies Revenue, Sales and Market Share by Big Type (2017-2022)
5.1.1 Global Precision Cancer Therapies Sales and Market Share by Big Type (2017-2022)
5.1.2 Global Precision Cancer Therapies Revenue and Market Share by Big Type (2017-2022)
5.2 Hormone Therapy Sales Growth Rate and Price
5.2.1 Global Hormone Therapy Sales Growth Rate (2017-2022)
5.2.2 Global Hormone Therapy Price (2017-2022)
5.3 Immunotherapies Sales Growth Rate and Price
5.3.1 Global Immunotherapies Sales Growth Rate (2017-2022)
5.3.2 Global Immunotherapies Price (2017-2022)
5.4 Targeted Therapy Sales Growth Rate and Price
5.4.1 Global Targeted Therapy Sales Growth Rate (2017-2022)
5.4.2 Global Targeted Therapy Price (2017-2022)
5.5 Monoclonal Antibody Therapy Sales Growth Rate and Price
5.5.1 Global Monoclonal Antibody Therapy Sales Growth Rate (2017-2022)
5.5.2 Global Monoclonal Antibody Therapy Price (2017-2022)
5.6 Gene Therapy Sales Growth Rate and Price
5.6.1 Global Gene Therapy Sales Growth Rate (2017-2022)
5.6.2 Global Gene Therapy Price (2017-2022)
6 Global Precision Cancer Therapies Market Segment by Big Application
6.1 Global Precision Cancer Therapies Sales Market Share by Big Application (2017-2022)
6.2 Hospitals Sales Growth Rate (2017-2022)
6.3 Diagnostic Centers Sales Growth Rate (2017-2022)
6.4 Oncology Clinics Sales Growth Rate (2017-2022)
6.5 Research Institutes Sales Growth Rate (2017-2022)
7 Global Precision Cancer Therapies Forecast
7.1 Global Precision Cancer Therapies Revenue, Sales and Growth Rate (2022-2027)
7.2 Precision Cancer Therapies Market Forecast by Regions (2022-2027)
7.2.1 North America Precision Cancer Therapies Market Forecast (2022-2027)
7.2.2 Europe Precision Cancer Therapies Market Forecast (2022-2027)
7.2.3 China Precision Cancer Therapies Market Forecast (2022-2027)
7.2.4 Japan Precision Cancer Therapies Market Forecast (2022-2027)
7.2.5 Southeast Asia Precision Cancer Therapies Market Forecast (2022-2027)
7.2.6 Other Regions Precision Cancer Therapies Market Forecast (2022-2027)
7.3 Precision Cancer Therapies Market Forecast by Type (2022-2027)
7.3.1 Global Precision Cancer Therapies Sales Forecast by Type (2022-2027)
7.3.2 Global Precision Cancer Therapies Market Share Forecast by Type (2022-2027)
7.4 Precision Cancer Therapies Market Forecast by Application (2022-2027)
7.4.1 Global Precision Cancer Therapies Sales Forecast by Application (2022-2027)
7.4.2 Global Precision Cancer Therapies Market Share Forecast by Application (2022-2027)
8 Market Analysis
8.1.1 Market Overview
8.1.2 Market Opportunities
8.1.3 Market Risk
8.1.4 Market Driving Force
8.1.5 Porter's Five Forces Analysis
8.1.6 SWOT Analysis
9 Precision Cancer Therapies Related Market Analysis
9.1 Upstream Analysis
9.1.1 Macro Analysis of Upstream Markets
9.1.2 Key Players in Upstream Markets
9.1.3 Upstream Market Trend Analysis
9.1.4 Precision Cancer Therapies Manufacturing Cost Analysis
9.2 Downstream Market Analysis
9.2.1 Macro Analysis of Down Markets
9.2.2 Key Players in Down Markets
9.2.3 Downstream Market Trend Analysis
9.2.4 Sales Channel, Distributors, Traders and Dealers
10 Research Findings and Conclusion
List of Tables and Figures
Figure Product Picture Precision Cancer Therapies
Figure Market Concentration Ratio and Market Maturity Analysis of Precision Cancer Therapies
Figure Bottom-up and Top-down Approaches for This Report
Figure Part of Our External Database
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Precision Cancer Therapies Market Size by Big Type
Figure Global Market Share of Precision Cancer Therapies by Big Type in 2021
Figure Hormone Therapy Picture (2017-2022)
Figure Immunotherapies Picture (2017-2022)
Figure Targeted Therapy Picture (2017-2022)
Figure Monoclonal Antibody Therapy Picture (2017-2022)
Global Precision Cancer Therapies Market Size by Big Application
Table Global Precision Cancer Therapies Market Size by Application
Figure Global Precision Cancer Therapies Market Share by Big Application in 2021
Figure Hospitals Picture
Figure Diagnostic Centers Picture
Figure Oncology Clinics Picture
Figure Research Institutes Picture
Table Global Precision Cancer Therapies Comparison by Regions (M USD) (2017-2027)
Figure Global Precision Cancer Therapies Market Size (Million US$) (2017-2027)
Figure North America Precision Cancer Therapies Revenue (Million US$) Growth Rate (2017-2027)
Figure Europe Precision Cancer Therapies Revenue (Million US$) Growth Rate (2017-2027)
Figure China Precision Cancer Therapies Revenue (Million US$) Growth Rate (2017-2027)
Figure Japan Precision Cancer Therapies Revenue (Million US$) Growth Rate (2017-2027)
Figure Southeast Asia Precision Cancer Therapies Revenue (Million US$) Growth Rate (2017-2027)
Table Business Impact Assessment - Covid-19
Table Market Trends and Precision Cancer Therapies Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Precision Cancer Therapies Sales by Manufacturer (2017-2022)
Figure Global Precision Cancer Therapies Sales Market Share by Manufacturer in 2021
Table Global Precision Cancer Therapies Revenue by Manufacturer (2017-2022)
Figure Global Precision Cancer Therapies Revenue Market Share by Manufacturer in 2021
Table Global Precision Cancer Therapies Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Precision Cancer Therapies Manufacturer (Revenue) Market Share in 2021
Figure Top 10 Precision Cancer Therapies Manufacturer (Revenue) Market Share in 2021
Table Date of Key Manufacturers Enter into Precision Cancer Therapies Market
Table Key Manufacturers Precision Cancer Therapies Product Type
Table Mergers & Acquisitions Planning
Table Abbott Laboratories Company Profile
Table Precision Cancer Therapies Product Introduction, Application and Specification of Abbott Laboratories
Table Precision Cancer Therapies Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company One 2017-2022
Table Company One Main Business
Table Company One Recent Development
Table Bayer HealthCare Company Profile
Table Precision Cancer Therapies Product Introduction, Application and Specification of Bayer HealthCare
Table Precision Cancer Therapies Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Bayer HealthCare Recent Development
Table GlaxoSmithKline Company Profile
Table Precision Cancer Therapies Product Introduction, Application and Specification of GlaxoSmithKline
Table Precision Cancer Therapies Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table GlaxoSmithKline Main Business
Table GlaxoSmithKline Recent Development
Table OncoGenex Pharmaceuticals Company Profile
Table Precision Cancer Therapies Product Introduction, Application and Specification of OncoGenex Pharmaceuticals
Table Precision Cancer Therapies Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table OncoGenex Pharmaceuticals Main Business
Table OncoGenex Pharmaceuticals Recent Development
Table OncoGenex Pharmaceuticals Main Business
Table OncoGenex Pharmaceuticals Recent Development
Table Hospira Company Profile
Table Precision Cancer Therapies Product Introduction, Application and Specification of Hospira
Table Precision Cancer Therapies Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Hospira Main Business
Table Hospira Recent Development
Table Boehringer Ingelheim Company Profile
Table Precision Cancer Therapies Product Introduction, Application and Specification of Boehringer Ingelheim
Table Precision Cancer Therapies Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Boehringer Ingelheim Main Business
Table Boehringer Ingelheim Recent Development
Table AstraZeneca Company Profile
Table Precision Cancer Therapies Product Introduction, Application and Specification of AstraZeneca
Table Precision Cancer Therapies Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table AstraZeneca Main Business
Table AstraZeneca Recent Development
Table Aveo Pharmaceuticals Company Profile
Table Precision Cancer Therapies Product Introduction, Application and Specification of Aveo Pharmaceuticals
Table Precision Cancer Therapies Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Aveo Pharmaceuticals Main Business
Table Aveo Pharmaceuticals Recent Development
Figure Global Precision Cancer Therapies Sales and Growth Rate (2017-2022)
Figure Global Precision Cancer Therapies Revenue and Growth Rate (2017-2022)
Table Global Precision Cancer Therapies Sales by Regions (2017-2022)
Figure Global Precision Cancer Therapies Sales Market Share by Regions in 2021
Table Global Precision Cancer Therapies Revenue by Regions (2017-2022)
Figure Global Precision Cancer Therapies Revenue Market Share by Regions in 2021
Figure North America Precision Cancer Therapies Sales and Growth Rate (2017-2022)
Figure Europe Precision Cancer Therapies Sales and Growth Rate (2017-2022)
Figure China Precision Cancer Therapies Sales and Growth Rate (2017-2022)
Figure Japan Precision Cancer Therapies Sales and Growth Rate (2017-2022)
Figure Southeast Asia Precision Cancer Therapies Sales and Growth Rate (2017-2022)
Figure Other Regions Precision Cancer Therapies Sales and Growth Rate (2017-2022)
Table Global Precision Cancer Therapies Sales by Big Type (2017-2022)
Table Global Precision Cancer Therapies Sales Market Share by Big Type (2017-2022)
Figure Global Precision Cancer Therapies Sales Market Share by Big Type in 2019
Table Global Precision Cancer Therapies Revenue by Big Type (2017-2022)
Table Global Precision Cancer Therapies Revenue Market Share by Big Type (2017-2022)
Table Global Precision Cancer Therapies Revenue Market Share by Big Type in 2019
Figure Global Hormone Therapy Sales Growth Rate (2017-2022)
Figure Global Hormone Therapy Price (2017-2022)
Figure Global Immunotherapies Sales Growth Rate (2017-2022)
Figure Global Immunotherapies Price (2017-2022)
Figure Global Targeted Therapy Sales Growth Rate (2017-2022)
Figure Global Targeted Therapy Price (2017-2022)
Figure Global Monoclonal Antibody Therapy Sales Growth Rate (2017-2022)
Figure Global Monoclonal Antibody Therapy Price (2017-2022)
Table Global Precision Cancer Therapies Sales by Big Application (2017-2022)
Table Global Precision Cancer Therapies Sales Market Share by Big Application (2017-2022)
Figure Global Precision Cancer Therapies Sales Market Share by Big Application in 2019
Figure Global Hospitals Sales Growth Rate (2017-2022)
Figure Global Diagnostic Centers Sales Growth Rate (2017-2022)
Figure Global Oncology Clinics Sales Growth Rate (2017-2022)
Figure Global Research Institutes Sales Growth Rate (2017-2022)
Figure Global Precision Cancer Therapies Sales and Growth Rate (2022-2027)
Figure Global Precision Cancer Therapies Revenue and Growth Rate (2022-2027)
Table Global Precision Cancer Therapies Sales Forecast by Regions (2022-2027)
Table Global Precision Cancer Therapies Market Share Forecast by Regions (2022-2027)
Figure North America Sales Precision Cancer Therapies Market Forecast (2022-2027)
Figure Europe Sales Precision Cancer Therapies Market Forecast (2022-2027)
Figure China Sales Precision Cancer Therapies Market Forecast (2022-2027)
Figure Japan Sales Precision Cancer Therapies Market Forecast (2022-2027)
Figure Southeast Asia Sales Precision Cancer Therapies Market Forecast (2022-2027)
Figure Other Regions Sales Precision Cancer Therapies Market Forecast (2022-2027)
Table Global Precision Cancer Therapies Sales Forecast by Type (2022-2027)
Table Global Precision Cancer Therapies Market Share Forecast by Type (2022-2027)
Table Global Precision Cancer Therapies Sales Forecast by Application (2022-2027)
Table Global Precision Cancer Therapies Market Share Forecast by Application (2022-2027)
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Figure Porter's Five Forces Analysis
Table Macro Analysis of Upstream Markets
Table Key Players in Upstream Markets
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Precision Cancer Therapies
Table Macro Analysis of Down Markets
Table Key Players in Down Markets
Table Key Players of Downstream Markets
Figure Sales Channel
Figure North America Precision Cancer Therapies Sales (K Units) Growth Rate Forecast (2021-2025)
Figure North America Precision Cancer Therapies Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Europe Precision Cancer Therapies Sales (K Units) Growth Rate Forecast (2021-2025)
Figure Europe Precision Cancer Therapies Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Japan Precision Cancer Therapies Production (K Units) Growth Rate Forecast (2021-2025)
Figure Japan Precision Cancer Therapies Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure China Precision Cancer Therapies Production (K Units) Growth Rate Forecast (2021-2025)
Figure China Precision Cancer Therapies Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Methodology/Research Approach
Figure Market Size Estimation
Figure Author List
Abbott Laboratories
Bayer HealthCare
GlaxoSmithKline
OncoGenex Pharmaceuticals
Hospira
Boehringer Ingelheim
Global Freckle-removing Medical and Beau..
The global market for Freckle-removing Medical and Beauty Eq..
+16467917070US (Toll Free)